Cargando…
Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort
OBJECTIVES: Phaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumours with malignant potential and a hereditary basis in almost 40% of patients. Germline genetic testing has transformed the management of PPGL enabling stratification of surveillance approaches, earlier diagnosis an...
Autores principales: | Winzeler, Bettina, Tufton, Nicola, S. Lim, Eugenie, Challis, Ben G., Park, Soo‐Mi, Izatt, Louise, Carroll, Paul V., Velusamy, Anand, Hulse, Tony, Whitelaw, Benjamin C., Martin, Ezequiel, Rodger, Fay, Maranian, Melanie, Clark, Graeme R., A. Akker, Scott, Maher, Eamonn R., Casey, Ruth T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543043/ https://www.ncbi.nlm.nih.gov/pubmed/34870338 http://dx.doi.org/10.1111/cen.14639 |
Ejemplares similares
-
Precision Medicine in Phaeochromocytoma and Paraganglioma
por: Winzeler, Bettina, et al.
Publicado: (2021) -
Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
por: Luchetti, Andrea, et al.
Publicado: (2015) -
The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas
por: Tufton, N, et al.
Publicado: (2022) -
Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers
por: Wong, Mei Yin, et al.
Publicado: (2019) -
Predictors of outcome in phaeochromocytomas and paragangliomas
por: Nicolas, Marlo, et al.
Publicado: (2017)